Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Restructure
Pharma
$2.4B gene therapy impairment sparks Roche restructure
Roche has recently launched a “fundamental reorganization” of its Spark Therapeutics gene therapy unit and recorded a $2.4 billion full impairment.
Angus Liu
Mar 10, 2025 3:15pm
Astellas shifts investment focus to later-stage programs: exec
Feb 12, 2025 1:30pm
As new drugs deliver, BMS explores further efficiency moves
Oct 31, 2024 10:27am
Bluebird bio lays off 25% of workforce
Sep 24, 2024 10:19am
BioMarin lays off 225 more staffers under new corporate strategy
Aug 29, 2024 4:30am
BMS lays off 117 in New Jersey in staggered wave of cuts
Aug 5, 2024 12:58pm
